AUVELITY in Agitation Associated with Dementia due to Alzheimer’s Disease FDA Approval Call | Axsome Therapeutics, Inc.

Event
Details

Event Details

News Releases Events

AUVELITY in Agitation Associated with Dementia due to Alzheimer’s Disease FDA Approval Call

May 01, 2026 at 8:00 AM EDT

Click here for Webcast

Supporting Materials

AUVELITY in Agitation Associated with Dementia due to Alzheimer’s Disease FDA Approval Call Presentation 4.7 MB